Fundraising FoxCaspian Therapeutics
San Diego, US · Founded 2026 · 3 known investors
Find your way into Caspian Therapeutics
Founders & leadership
RH
Robert H. SpencerExecutive
Board
SL
Spike LoyBoard director
TE
Troy E. WilsonBoard director
Investors · 3
Biotechnology Value FundreportedSan Francisco
How we know: funding news · Not right? Tell us
InvusreportedNew York
How we know: funding news · Not right? Tell us
Leaps by BayerreportedLeverkusen
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$50M disclosed across 1 round · 2026
▶$50MraisedSep 2026 · 43 investors · BiotechnologyRule 506(b)
▶$50MraisedSep 2026 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert H. SpencerExecutive Officer
- Troy E. WilsonDirector
- Spike LoyDirector
- Offering amount
- $50M
- Amount sold
- $50M
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Caspian Therapeutics's investors?
- Caspian Therapeutics's investors include Biotechnology Value Fund, Invus, Leaps by Bayer.
- How much funding has Caspian Therapeutics raised?
- Caspian Therapeutics has disclosed $50M raised across 1 round.
- Where is Caspian Therapeutics headquartered?
- Caspian Therapeutics is headquartered in San Diego, US.